Cargando…
Recent computational drug repositioning strategies against SARS-CoV-2
Since COVID-19 emerged in 2019, significant levels of suffering and disruption have been caused on a global scale. Although vaccines have become widely used, the virus has shown its potential for evading immunities or acquiring other novel characteristics. Whether current drug treatments are still e...
Autores principales: | Lu, Lu, Qin, Jiale, Chen, Jiandong, Yu, Na, Miyano, Satoru, Deng, Zhenzhong, Li, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575573/ https://www.ncbi.nlm.nih.gov/pubmed/36277237 http://dx.doi.org/10.1016/j.csbj.2022.10.017 |
Ejemplares similares
-
Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
por: Zhang, Jiayu, et al.
Publicado: (2022) -
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation
por: Asberry, Andrew Michael, et al.
Publicado: (2022) -
Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers
por: Zhao, Yan, et al.
Publicado: (2022) -
scDrug: From single-cell RNA-seq to drug response prediction
por: Hsieh, Chiao-Yu, et al.
Publicado: (2022) -
Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry
por: Bai, Yunpeng, et al.
Publicado: (2021)